The war against generics is going well for AstraZeneca these days.
A federal judge in New Jersey just granted the company summary judgment in a case where Teva and Sandoz (Novartis’s generics arm) were seeking to sell generic copies of AstraZeneca’s Seroquel. The ruling means the company isn’t likely to face generic competition for the antipsychotic [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment